Plus therapeutics to present at the thinkequity conference

Austin, texas, oct. 18, 2022 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, announced today that marc hedrick, m.d., president and chief executive officer, will present at the thinkequity conference on wednesday, october 26, 2022, at 3:00 p.m. et, and host investor meetings. the conference is being held at the mandarin oriental, new york in new york city.
PSTV Ratings Summary
PSTV Quant Ranking